A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

An 8 Weeks Open Label National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

This study is to assess the efficacy of the fixed combination of Valsartan and Amlodipine in hypertensive patients uncontrolled by monotherapy.

Inclusion Criteria:

• Patient uncontrolled by mono-therapy for at least 8 weeks, having B.P.>/= 140/90 mmHg in non diabetics or >/= 130/80 mmHg in diabetics

Exclusion Criteria:

• Patient having B.P.>= 180/110 mmHg in non diabetics or >= 160/100 mmHg in diabetics
• Type 1 Diabetes or uncontrolled type 2 Diabetes.
• PCI in last 12 months.
• Concomitant unstable angina. Other protocol-defined inclusion/exclusion criteria may apply